IMMUNE COMPLEX
Immune Complex Corporation (ICC), founded in 1994, focuses on the development of vaccines for infectious diseases based on its proprietary antigen delivery platform, CorVax(TM). ICC's first vaccine candidate based on this delivery platform, MalariVax(TM), is scheduled to enter Phase I clinical trials in 2001.
Similar Organizations
AcSentient
AcSentient develops and commercializes specialty, niche prescription drugs.
Living Pharma
Living Pharma, Inc. develops Personalized CAR T Cell Therapy™
M6P Therapeutics
M6P Therapeutics develops biotechnology advances for lysosomal storage diseases.
MedFluid
Medfluid is are committed to optimizing the quality of patient-specific medication of infectious disease
NXT Biologics
NXT Biologics develops therapeutics for lung infections and respiratory illnesses.